Browse 14 Medical companies funded by Matrix Partners China. See funding amounts, founder contacts, and investment details.
Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology.
Alioth focuses on the development and application of technical products for pharmaceutical process technology.
KYinno is a drug development company that is dedicated to oncology drug development with a focus on immune treatments against cancer.
GRIT Biotechnology develops tumor infiltration lymphocytes immunotherapy for solid tumors.
Haoyayi is an online dental medical service platform.
Ronovo Surgical is an emerging medtech company focused on innovating minimally invasive (MIS) and digital surgery.
Ennovabio is a Chinese drug developer that focuses on creating drugs targeting brain glioma.
TOPI Imaging Technology is a medical device firm providing OCT retinal diagnostic system and sweep optical biometer.
Lingyi Bio is a rare disease animal model functional verification platform and gene therapy developer.
Zenshine Pharma is a clinical-stage biopharmaceutical company with a focus on small molecule drugs for cancer and autoimmune diseases.
Qihan Biotech is a gene-editing organ transplantation technology developer.
Ucello Therapeutics is engaged in development of allogeneic cell therapies using its proprietary CAR-T cell technology platform CBT-X20.
Lansion Biotechnology is specialized in research & development, production, sell, services of in vitro diagnostic reagents and devices.
UNIMED provides integrated medical service models.
View all companies funded by Matrix Partners China across every industry and funding stage.
View Full Matrix Partners China Portfolio